UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000030454
Receipt number R000034770
Scientific Title Living/ deceased donor intestinal transplantation using standardized immunosuppression protocol
Date of disclosure of the study information 2017/12/18
Last modified on 2017/12/18 18:44:33

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Living/ deceased donor intestinal transplantation using standardized immunosuppression protocol

Acronym

Intestinal transplantation using standardized immunosuppression protocol

Scientific Title

Living/ deceased donor intestinal transplantation using standardized immunosuppression protocol

Scientific Title:Acronym

Intestinal transplantation using standardized immunosuppression protocol

Region

Japan


Condition

Condition

irreversible intestinal failure

Classification by specialty

Hepato-biliary-pancreatic medicine Gastrointestinal surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To define the efficacy of intestinal transplantation for patients with irreversible intestinal failure

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Patient and graft survival after intestinal transplantation
rejection rate after transplantation

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine Maneuver

Interventions/Control_1

Transplantation group using standardized immunosuppression protocol

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit

60 years-old >

Gender

Male and Female

Key inclusion criteria

Patients with irreversible intestinal failure complicated with bellow conditions.
1. Thrombosis/ Occlusion of central venous access
2. intestinal failure associated liver disease
3. Poor quality of life

Key exclusion criteria

Patients having allergy to immunosuppressive drug
Pregnant or breast feeding female patients
Patients having uncontrollable infection
Patients having uncontrollable malignancy
Patients having uncontrollable mental disorders

Target sample size

5


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Masaki Nio

Organization

Tohoku University Graduate School of Medicine

Division name

Department of Pediatric Surgery

Zip code


Address

1-1 Seiryo-machi, Aobaku, Sendai

TEL

022-717-7237

Email

mnio@ped-surg.med.tohoku.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Motoshi Wada

Organization

Tohoku University Graduate School of Medicine

Division name

Department of Pediatric Surgery

Zip code


Address

1-1 Seiryo-machi, Aobaku, Sendai

TEL

022-717-7237

Homepage URL


Email

wada@ped-surg.med.tohoku.ac.jp


Sponsor or person

Institute

Tohoku University

Institute

Department

Personal name



Funding Source

Organization

Tohoku University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 12 Month 18 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2017 Year 12 Month 20 Day

Date of IRB


Anticipated trial start date

2018 Year 01 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 12 Month 18 Day

Last modified on

2017 Year 12 Month 18 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034770


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name